BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 4064049)

  • 1. Aneuploidy as a marker of minimal residual disease in leukemia.
    Walle AJ; Niedermayer W
    Cancer Detect Prev; 1985; 8(1-2):303-15. PubMed ID: 4064049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Flow cytometry in the determination of DNA aneuploidy in patients with acute leukemias].
    Shmarov DA; Kuchma IuM; Miterev GIu; Kozinets GI
    Ter Arkh; 1996; 68(7):11-4. PubMed ID: 8928064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of FCM-DNA measurement in detecting minimal residual disease in leukemia.
    Zhang RX; Yao EG
    Chin Med J (Engl); 1990 Oct; 103(10):826-30. PubMed ID: 2125256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Analysis of DNA aneuploidy as a tumor marker].
    Takamoto S
    Gan To Kagaku Ryoho; 1989 Jul; 16(7):2329-37. PubMed ID: 2751314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of hematologic malignancies by flow cytometry.
    Barlogie B; Latreille J; Freireich EJ; Fu CT; Mellard D; Meistrich M; Andreeff M
    Blood Cells; 1980; 6(4):719-44. PubMed ID: 7008871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [DNA cytometry analysis in childhood tumors].
    Eckschlager T; Pilát D; Kodet R; Starý J; Jasinská J; Hrusák O
    Cas Lek Cesk; 1995 May; 134(10):302-5. PubMed ID: 7788648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA flow-cytometry on fine needle aspiration cytology of lymph node: how helpful is it?
    Dey P; Saikia UN; Vohra H
    Indian J Pathol Microbiol; 2000 Apr; 43(2):127-30. PubMed ID: 11217267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Flow cytometry in the detection of residual disease].
    Lamy B; Hervé P; Tissot C; Peters A
    Pathol Biol (Paris); 1988 Jan; 36(1):29-36. PubMed ID: 2966335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of residual aneuploid leukemic cells by "continuous gating".
    Kleine HD; Zech I; Nowak R; Oelschlägel U; Kundt G; Freund M
    Cytometry; 1999 May; 36(1):71-6. PubMed ID: 10331629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined cell sorting and FISH for detection of minimal residual disease in bone marrow of children with acute leukemia or solid tumors.
    Sainati L; Spinelli M; Leszl A; Cocito MG; Stella M; Basso G
    Eur J Histochem; 1997; 41 Suppl 2():167-8. PubMed ID: 9859833
    [No Abstract]   [Full Text] [Related]  

  • 11. Clonality assessment of lymphoproliferative disorders by multiparameter flow cytometry of paraffin-embedded tissue: an additional diagnostic tool in surgical pathology.
    Leers MP; Theunissen PH; Ramaekers FC; Schutte B; Nap M
    Hum Pathol; 2000 Apr; 31(4):422-7. PubMed ID: 10821487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of cytogenetics, interphase cytogenetics, and DNA flow cytometry in bone tumors.
    Tarkkanen M; Nordling S; Böhling T; Kivioja A; Karaharju E Szymanska J; Elomaa I; Knuutila S
    Cytometry; 1996 Sep; 26(3):185-91. PubMed ID: 8889389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computerized image analysis and flow cytometric evaluation of ovarian borderline tumors: a study of 24 cases.
    Esposito MJ; Fuchs A
    Cytometry; 1994 Dec; 18(4):218-22. PubMed ID: 7895528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flow cytometric DNA quantification in immunophenotyped cells as a sensitive method for determination of aneuploid multiple myeloma cells in peripheral blood stem cell harvests and bone marrow after therapy.
    Nowak R; Oelschlägel U; Range U; Bergmann S; Bornhäuser M; Hölig C; Schuler U; Krebs U; Günther H; Kroschinsky F; Ehninger G
    Bone Marrow Transplant; 1999 May; 23(9):895-900. PubMed ID: 10338044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell size, DNA, and cytokeratin analysis of human head and neck tumors by flow cytometry.
    Bijman JT; Wagener DJ; Wessels JM; van den Broek P; Ramaekers FC
    Cytometry; 1986 Jan; 7(1):76-81. PubMed ID: 2419057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of image (CAS 200) and flow cytometry determined DNA content of paraffin-embedded Hodgkin's disease tissue.
    Erdkamp FL; Schouten HC; Breed WP; Janssen WC; Hoffmann JJ; Reynders M; Schutte B; Blijham GH
    Hematol Pathol; 1994; 8(3):75-84. PubMed ID: 7982854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA content analysis of peripheral blood B-lymphocytes in plasma cell malignancies.
    Montecucco C; Riccardi A; Mazzini G; Danova M; Ucci G; Giordano PA
    Basic Appl Histochem; 1985; 29(3):275-82. PubMed ID: 3877500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flow cytometry analysis of malignant tumors of the head and neck--differences between two methods in the recognition of aneuploidy.
    Wennerberg J; Baldetorp B; Wahlberg P; Zätterström UK
    Anal Cell Pathol; 1996 Dec; 12(3):125-36. PubMed ID: 9025989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proliferative characteristics of primary and metastatic human solid tumors by DNA flow cytometry.
    Frankfurt OS; Greco WR; Slocum HK; Arbuck SG; Gamarra M; Pavelic ZP; Rustum YM
    Cytometry; 1984 Nov; 5(6):629-35. PubMed ID: 6518938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA content analysis by flow cytometry and cytogenetic analysis in mycosis fungoides and Sézary syndrome.
    Bunn PA; Whang-Peng J; Carney DN; Schlam ML; Knutsen T; Gazdar AF
    J Clin Invest; 1980 Jun; 65(6):1440-8. PubMed ID: 6997334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.